Crenessity
- Product NDC
- 70370-5250
- 11-digit product format
- 703705250
- Labeler code
- 70370
- Product ID
- 70370-5250_f5cc43fd-6e18-4a06-8c9f-bd80ea847e83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- crinecerfont
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Neurocrine Biosciences, Inc.
- Application
- NDA218820
- Marketing category
- NDA
- Marketing start
- 2024-12-13
- Substance
- CRINECERFONT
- Active strength
- 50 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Crenessity
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CRINECERFONT | 50 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MFT24BX55I |
| Rxcui | 2701391, 2701397, 2701399, 2701401, 2701403, 2701405, 2701409, 2701413 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70370-5250-1 | Crenessity | 30 mL in 1 BOTTLE | SOLUTION | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70370-5250 | CRENESSITY (CRINECERFONT) CAPSULE CRENESSITY (CRINECERFONT) SOLUTION [NEUROCRINE BIOSCIENCES, INC.] | 5 | Current NDC, 1 package rows | 20250213_fd3a6fbd-9137-428a-ba46-df6606f07d28.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70370-5250-1 | 70370525001 | 30 mL in 1 BOTTLE (70370-5250-1) | 30 ml | 2024-12-13 | No | No | Historical |